Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer
Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance. We carried out a genome-wide ass...
Saved in:
Published in | Cancer epidemiology, biomarkers & prevention Vol. 30; no. 9; pp. 1669 - 1680 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance.
We carried out a genome-wide association study (GWAS) of PFS in 2,352 women with EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy.
We found seven SNPs at 12q24.33 associated with PFS (
< 5 × 10
), the top SNP being rs10794418 (HR = 1.24; 95% CI, 1.15-1.34;
= 1.47 × 10
). High expression of a nearby gene,
, is associated with shorter PFS in EOC, and with poor prognosis in other cancers. SNP rs10794418 is also associated with expression of
in ovarian tumors, with the allele associated with shorter PFS being associated with higher expression, and chromatin interactions were detected between the
promoter and associated SNPs in serous and endometrioid EOC cell lines. ULK1 knockout ovarian cancer cell lines showed significantly increased sensitivity to carboplatin
.
The locus at 12q24.33 represents one of the first genome-wide significant loci for survival for any cancer.
is a plausible candidate for the target of this association.
This finding provides insight into genetic markers associated with EOC outcome and potential treatment options.
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS These two authors contributed equally MCJQ and SJ performed the statistical analyses. DG performed the HiChIP analysis. KMC performed 3C experiments and luciferase assays, along with AC. JB and TO’M performed in bioinformatic analyses. JPT and MR provided technical data support. AdeF performed expression analyses through kmPLOTTER. A-MP provided expression results from the AOCS. MJCG and GCT drafted the manuscript. JSO, PG, BG, SLE, YL and PDPP assisted with the design of the study. All other authors provided phenotypic data and DNA samples. All authors read and approved the final manuscript. |
ISSN: | 1055-9965 1538-7755 1538-7755 |
DOI: | 10.1158/1055-9965.EPI-20-1817 |